Analysis of clinicopathological factors and CHRNB2 expression showed no correlation with tumor markers, tumor depth, and lymph node metastasis, and high CHRNB2 was an independent poor prognostic factor along with wall depth T4 in multivariate analysis. Here, CHRNB2 is linked to metastatic malignant neoplasm in the lymph nodes.